Sign In
Buy MRNA
$51.59
+2.53 (+5.16%)
At Close: Jun 04, 2026
Moderna (MRNA) Stock Moves -0.55%: What You Should Know
09:50pm, Monday, 11'th Jul 2022 Zacks Investment Research
Moderna (MRNA) closed the most recent trading day at $175.26, moving -0.55% from the previous trading session.
Nasdaq leads stocks to lower finish as investors weigh restrictions in China, await U.S. inflation data
08:34pm, Monday, 11'th Jul 2022 MarketWatch
U.S. stocks end lower on Monday as China COVID fears spark fresh global growth concerns.
PFE, BNTX's COVID Jab Gets FDA's Full Nod for Adolescents
07:17pm, Monday, 11'th Jul 2022 Zacks Investment Research
Pfizer (PFE) and partner BioNTech's (BNTX) Comirnaty is the first COVID-19 vaccine to receive full approval in the United States for use in adolescents aged 12 years and older.
New omicron variant worries experts as it spreads in India, and Moderna says new booster offers better protection against BA.4 and BA.5
05:58pm, Monday, 11'th Jul 2022 MarketWatch
A new, highly infectious subvariant of omicron is raising concerns among scientists and health experts as it spreads in India and other countries, including the U.S.
U.S. Stocks Tumble Over Heightened Inflation Fears
01:52pm, Monday, 11'th Jul 2022 Investing.com
Stock Market News for Jul 11, 2022
01:35pm, Monday, 11'th Jul 2022 Zacks Investment Research
Wall Street had a mixed day on Friday in a choppy session of trading.
Hershey And 2 Other Stocks Insiders Are Selling
12:36pm, Monday, 11'th Jul 2022 Benzinga
Better-than-expected nonfarm payroll figures released Friday have firmed expectations of a potential 75 bps rate hike at the Fed's July meeting. Investors, meanwhile, focused on some notable insider t
How Its New Vaccine Could Propel GSK's Growth
11:00am, Monday, 11'th Jul 2022 The Motley Fool
GSK leads the race to deliver a vaccine for an untreated infectious disease.
This Company Could Ease the Pain in a Bear Market
02:23pm, Saturday, 09'th Jul 2022 The Motley Fool
New product candidates aim to diversify into areas with a large unmet medical need.
Wall Street Breakfast: What Moved Markets
12:02pm, Saturday, 09'th Jul 2022 Seeking Alpha
Listen on the go! A daily podcast of Wall Street Breakfast will be available every morning on Seeking Alpha, iTunes, Stitcher and Spotify.
Why Jim Cramer Says Applied Materials Is 'Too Good A Company'
02:48pm, Friday, 08'th Jul 2022 Benzinga
On CNBC’s "Mad Money Lightning Round," Jim Cramer said Comstock Resources Inc (NYSE: CRK) is a "very cheap stock."
Cramer said Moderna Inc (NASDAQ: MRNA) has now come down enough. "I would want to
Company News for Jul 8, 2022
01:13pm, Friday, 08'th Jul 2022 Zacks Investment Research
Companies In The News Are: GME, MRNA, LCID, SLP.
Want to Beat the Bear Market? Try These 2 Stocks
10:00am, Friday, 08'th Jul 2022 The Motley Fool
There's plenty of growth ahead for these companies.
This Low-Float Stock Jumps Around 148%; Here's 64 Biggest Movers From Yesterday
08:15am, Friday, 08'th Jul 2022 Benzinga
Gainers
United Maritime Corporation (NASDAQ: USEA) climbed 147.6% to close at $7.08 on Thursday on heavy momentum following the company's recent listing on the Nasdaq Capital Market.
Grove Collabora
Novavax (NVAX) Stock Rallies 26.8% in a Month: Here's Why
04:03pm, Thursday, 07'th Jul 2022 Zacks Investment Research
FDA's advisory committee supports granting authorization to Novavax's (NVAX) COVID-19 vaccine for use in adults. The vaccine also receives authorization for use in adolescents in Europe.
